Cipla launches Yurpeak (tirzepatide) for obesity and type 2 diabetes management in India
Company to distribute and promote the once-weekly injectable therapy following Lilly’s DCGI approval
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pharmacists can be true changemakers in population health
Manjiri Gharat,FIP India Envoy; VP,SEARPharm Forum of FIP; I/C Principal,K.M.Kundnani Pharmacy Polytechnic,Ulhasnagar; Former…
Servier India secures CDSCO approval for Vorasidenib for Grade 2 IDH-mutant glioma
Approval enables access to targeted therapy for adults and adolescents aged 12 and above following surgery
USC India Awards honours Kiran Mazumdar-Shaw with Business Management Award
Biocon Group Chairperson recognised in Mumbai ceremony for contributions to global healthcare and biotechnology
Zydus Lifesciences signs licensing deal with Formycon
Formycon to develop and supply Pembrolizumab biosimilar FYB206, while Zydus Lifesciences will commercialise the product in the USA…
From compliance to commitment: India Pharma Inc’s safety reckoning
A spate of fatal incidents at pharma plants has exposed critical gaps in workplace safety. With growing ESG scrutiny and global…
Pharma sector records higher deal value in November 2025
GlobalData data shows increases in mergers, acquisitions and venture funding activity year-on-year
Immutep and Dr Reddy’s enter Exclusive Licensing Agreement for Eftilagimod Alfa
Deal covers commercialisation and development rights outside key regulated markets
Anuh Pharma receives Certificate of Suitability from EDQM for Sulfadimethoxine
Company shares regulatory milestone and product details
Satya Karm Punia joins Putin’s India visit as part of official business delegation
Indian-origin pharma leader represented Russia in bilateral trade discussions